Skip to main content

Table 2 Baseline sociodemographic and clinical characteristics of 20 consenting participants

From: Pain management in inflammatory bowel disease: feasibility of an online therapist-supported CBT-based self-management intervention

Characteristic Recruited participants (n = 20)
Sociodemographic
 Age, mean (SD), yr 38.40 (9.87)
 Female 16 (80)
 English/Welsh/Scottish/N Irish/British 19 (95)
 University degree or higher 13 (65)
Employment status
 Employed full-time 10 (50)
 Employed part-time 2
 Full- or part-time education 2
 Full-time domestic 1 (5)
 Retired 1 (5)
 Unemployed 4 (20)
Relationship status
 Married/civil partnership 9 (45)
 Living with partner 5 (25)
 Divorced 1 (5)
 Single 5 (25)
Clinical
 Diagnosis (CD/UC/IBD-U) 16 (80)/4 (20)/0 (0)
 Disease duration mean (SD) (yrs) 13.20 (10.46)
 Faecal calprotectin mean (SD) ug/g 175.69 (205.69)
IBD medication
 5-ASA 6 (30)
 Thiopurines 4 (20)
 Anti-TNF (infliximab/adalimumab) 3 (15)/4 (20)
 Vedolizumab 1 (5)
 Steroids (methotrexate/budesonide/prednisolone) 3 (15) /3 (15) /2 (10)
 Ustekinumab 5 (25)
 None 2 (10)
 Previous surgery 12 (60)
Surgeries
 Resection 5 (25)
 Colectomy 3 (15)
 Stoma 2 (10)
Smoking history
 Current smoker 3 (15)
 Previous smoker 5 (25)
 Non-smoker 12 (60)
Pain locations
 Abdomen 18 (85)
 Joints 14 (70)
 Back 13 (65)
 Head 8 (40)
Pain medications
 Paracetamol 10 (50)
 Co-codamol 4 (20)
 Opioids 10 (50)
 Pregabalin 1 (5)
 NSAIDs 3 (15)
 Tricyclic antidepressants 3 (15)
 Antispasmodics 1 (5)
 Omeprazole 1 (5)
 Benzodiazepine 1 (5)
 Other (anti-diarrhoeal, anti-bile acid) 0 (0)
  1. NB count displayed as % unless otherwise specified